AGA Family of Websites:
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
April 28, 2020

New guideline recommends topical steroids as first-line treatment for EoE

AGA and the Joint Task Force on Allergy-Immunology Practice Parameters release new clinical guidelines for the management of eosinophilic esophagitis (EoE).

Share on facebook
Share on twitter
Share on linkedin
Share on email

A new guideline from AGA and the Joint Task Force for Allergy-Immunology Practice Parameters provides recommendations for the management of EoE in pediatric and adult patients. 

Key guideline highlights:
    • Topical steroids are recommended as a first-line treatment for EoE.
    • The guideline also recommends proton pump inhibition (PPI) therapy, diet therapy and esophageal dilation as treatment options.
    • The use of novel, targeted biologic therapies for EoE are being actively evaluated and more research is needed before these can be recommended.

Review the guideline for the complete recommendations.

Helpful links

This guideline was developed through a collaboration between AGA and the Joint Task Force for Allergy-Immunology Practice Parameters, which comprises the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma & Immunology. This guideline is jointly published in Gastroenterology and Annals of Allergy, Asthma and Immunology.

Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.